Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Apr;43(4):517–525. doi: 10.1038/bjc.1981.74

Heterophile binding of human antibodies to glycoproteins of retroviruses.

E A Cardoso
PMCID: PMC2010640  PMID: 6263306

Abstract

The binding of human immunoglobulin to Type C viruses has been analysed by radioimmunoassay. The assay is a double-antibody, solid-phase RIA, which has been optimized and calibrated using rabbit and human anti-MuLV sera. It detects varying concentrations of IgG binding to HL-23-V-1, a human Type C virus isolate, in all of a large number of human sera tested. As judged by inhibition with nonspecific glycoproteins, heterophile antigens and pure saccharides, this binding is to the glycoside moiety of the virus-envelope glycoproteins, in agreement with other recent reports. Nonspecific binding of this type stringently restricts the interpretation which can be placed on these and earlier data in man concerning antibodies to Type C viruses. It does not however exclude the possibility that Type C viruses do occur in man and do elicit antibody therein.

Full text

PDF
517

Images in this article

522Fig. 5
on p.522

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Walling M. J., Bushar G. S., Liu M., Hsu K. C. Natural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells from primates. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2491–2495. doi: 10.1073/pnas.73.7.2491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbacid M., Bolognesi D., Aaronson S. A. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1617–1621. doi: 10.1073/pnas.77.3.1617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burger M. M. Forssman antigen exposed on surface membrane after viral transformation. Nat New Biol. 1971 May 26;231(21):125–126. doi: 10.1038/newbio231125a0. [DOI] [PubMed] [Google Scholar]
  4. Chan E., Peters W. P., Sweet R. W., Ohno T., Kufe D. W., Spiegelman S., Gallo R. C., Gallagher R. E. Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells. Nature. 1976 Mar 18;260(5548):266–268. doi: 10.1038/260266a0. [DOI] [PubMed] [Google Scholar]
  5. Charman H. P., Kim N., White M., Marquardt H., Gilden R. V., Kawakami T. Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates. J Natl Cancer Inst. 1975 Dec;55(6):1419–1424. doi: 10.1093/jnci/55.6.1419. [DOI] [PubMed] [Google Scholar]
  6. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gallagher R. E., Gallo R. C. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Science. 1975 Jan 31;187(4174):350–353. doi: 10.1126/science.46123. [DOI] [PubMed] [Google Scholar]
  8. Henle G., Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976 Jan 15;17(1):1–7. doi: 10.1002/ijc.2910170102. [DOI] [PubMed] [Google Scholar]
  9. Hersh E. M., Hanna M. G., Jr, Gutterman J. U., Mavligit G., Yurconic M., Jr, Gschwind C. R. Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity. J Natl Cancer Inst. 1974 Aug;53(2):327–333. doi: 10.1093/jnci/53.2.327. [DOI] [PubMed] [Google Scholar]
  10. Ihle J. N., Denny T. P., Bolognesi D. P. Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. J Virol. 1976 Mar;17(3):727–736. doi: 10.1128/jvi.17.3.727-736.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Krakower J. M., Aaronson S. A. Seroepidemiologic assessment of feline leukaemia virus infection risk for man. Nature. 1978 Jun 8;273(5662):463–464. doi: 10.1038/273463a0. [DOI] [PubMed] [Google Scholar]
  12. Kurth R., Mikschy U. Human antibodies reactive with purified envelope antigens of primate type C tumor viruses. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5692–5696. doi: 10.1073/pnas.75.11.5692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kurth R., Teich N. M., Weiss R., Oliver R. T. Natural human antibodies reactive with primate type-C viral antigens. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1237–1241. doi: 10.1073/pnas.74.3.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Louie S., Curtis J. E., Till J. E., McCulloch E. A. Antibodies in human sera to oncorna virus-like proteins from normal or leukemia marrow cell cultures. J Exp Med. 1976 Nov 2;144(5):1243–1253. doi: 10.1084/jem.144.5.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Niederman J. C., Evans A. S., Subrahmanyan L., McCollum R. W. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med. 1970 Feb 12;282(7):361–365. doi: 10.1056/NEJM197002122820704. [DOI] [PubMed] [Google Scholar]
  16. Nowinski R. C., Kaehler S. L. Antibody to leukemia virus: widespread occurrence in inbred mice. Science. 1974 Sep 6;185(4154):869–871. doi: 10.1126/science.185.4154.869. [DOI] [PubMed] [Google Scholar]
  17. Okabe H., Gilden R. V., Hatanaka M., Stephenson J. R., Gallagher R. E., Aaronson S. A., Gallo R. C., Tronick S. R. Immunological and biochemical characterisation of type C viruses isolated from cultured human AML cells. Nature. 1976 Mar 18;260(5548):264–266. doi: 10.1038/260264a0. [DOI] [PubMed] [Google Scholar]
  18. Rowe W. P., Pugh W. E., Hartley J. W. Plaque assay techniques for murine leukemia viruses. Virology. 1970 Dec;42(4):1136–1139. doi: 10.1016/0042-6822(70)90362-4. [DOI] [PubMed] [Google Scholar]
  19. SVOBODA J. Presence of chicken tumour virus in the sarcoma of the adult rat inoculated after birth with Rous sarcoma tissue. Nature. 1960 Jun 18;186:980–981. doi: 10.1038/186980b0. [DOI] [PubMed] [Google Scholar]
  20. Snyder H. W., Jr, Fleissner E. Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1622–1626. doi: 10.1073/pnas.77.3.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snyder H. W., Jr, Pincus T., Fleissner E. Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses. Virology. 1976 Nov;75(1):60–73. doi: 10.1016/0042-6822(76)90007-6. [DOI] [PubMed] [Google Scholar]
  22. Stephenson J. R., Aaronson S. A. Search for antigens and antibodies crossreactive with type C viruses of the woolly monkeys and gibbon ape in animal models and in humans. Proc Natl Acad Sci U S A. 1976 May;73(5):1725–1729. doi: 10.1073/pnas.73.5.1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Teich N. M., Weiss R. A., Salahuddin S. Z., Gallagher R. E., Gillespie D. H., Gallo R. C. Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells. Nature. 1975 Aug 14;256(5518):551–555. doi: 10.1038/256551a0. [DOI] [PubMed] [Google Scholar]
  24. de-Thé G., Geser A., Day N. E., Tukei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bronkamm G. W., Feorino P. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978 Aug 24;274(5673):756–761. doi: 10.1038/274756a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES